Skip to main content
Top
Published in: Digestive Diseases and Sciences 5/2007

01-05-2007 | Original Paper

Gastric Tissue Oxidative Changes in Portal Hypertension and Cirrhosis

Authors: Yuksel Seckin, Murat M. M. Harputluoglu, Kadir Batcioglu, Melih Karincaoglu, Bulent Yildirim, Ramazan I. Oner, Burcin Uyumlu, Nurettin Aydogdu, Fatih Hilmioglu

Published in: Digestive Diseases and Sciences | Issue 5/2007

Login to get access

Abstract

Gastric mucosal lesions are very common in portal hypertension and cirrhosis. The aim of this study was to assess for oxidative gastric tissue damage in cirrhosis and evaluate relations with portal hypertension and cirrhosis parameters. The study included 30 patients with cirrhosis and 30 controls. Each patient's history, physical examination, and laboratory findings were recorded, and multiple biopsies of the gastric antrum were obtained at endoscopy. A set of antral biopsies was also collected from each control subject. Each tissue specimen was analyzed for levels of glutathione peroxidase (GPX), superoxide dismutase (SOD), and catalase (CAT) activity and level of malondialdehyde (MDA). Patients’ gastric GPX, SOD, and CAT levels were significantly lower, and MDA levels were higher, than in the control group. The GPX activity level in the specimens was moderately negatively correlated with portal vein diameter (P < 0.05, r=−0.45) and spleen length (P < 0.05, r=−0.45). In this study gastric tissue oxidative markers showed that antral oxidative factors worsen in cirrhosis. Oxidative stress may not be a clinical condition but it obviously shows gastric tissue damage and may explain many patients’ gastric lesions and hemorrhage.
Literature
1.
go back to reference Lowry OH, Rosebrough NJ, Farr AL (1952) Protein measurements with folin phenol reagent. J Biol Chem 193:265–271 Lowry OH, Rosebrough NJ, Farr AL (1952) Protein measurements with folin phenol reagent. J Biol Chem 193:265–271
2.
go back to reference Lawrence RA, Burk RF (1976) Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun 71(4):952–958 Lawrence RA, Burk RF (1976) Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun 71(4):952–958
3.
go back to reference McCord JM, Fridovich I (1969) Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol chem 244(22):6049–6055 McCord JM, Fridovich I (1969) Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol chem 244(22):6049–6055
4.
go back to reference Luck H (1963) Methods of enzymatic analysis, 2nd ed., Verlag Cheme, New York, Academic Press, pp 885–888 Luck H (1963) Methods of enzymatic analysis, 2nd ed., Verlag Cheme, New York, Academic Press, pp 885–888
5.
go back to reference Mihara M, Uchiyama M (1978) Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 86(1):271–278 Mihara M, Uchiyama M (1978) Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 86(1):271–278
6.
go back to reference Vigneri S, Termini R, Piraino A, Scialabba A, Pisciotta G, Fontana N (1991) The stomach in liver cirrhosis. Endoscopic, morphological, and clinical correlations. Gastroenterology 101:472–478PubMed Vigneri S, Termini R, Piraino A, Scialabba A, Pisciotta G, Fontana N (1991) The stomach in liver cirrhosis. Endoscopic, morphological, and clinical correlations. Gastroenterology 101:472–478PubMed
7.
go back to reference Merkel C, Schipilliti M, Bighin R, Bellini B, Angeli P, Bolognesi M, Vescovi F, Gatta A (2003) Portal hypertension and portal hypertensive gastropathy in patients with liver cirrhosis:A haemodynamic study. Dig Liver Dis 35:269–274PubMedCrossRef Merkel C, Schipilliti M, Bighin R, Bellini B, Angeli P, Bolognesi M, Vescovi F, Gatta A (2003) Portal hypertension and portal hypertensive gastropathy in patients with liver cirrhosis:A haemodynamic study. Dig Liver Dis 35:269–274PubMedCrossRef
8.
go back to reference Vigneri S, Scialabba A, Termini R, Germana B, Vianello F, Grassi SA, Plebani M, Di Mario F (1992) Pathophysiology of the gastric microcirculation. Ital J Gastroenterol 24:22–30PubMed Vigneri S, Scialabba A, Termini R, Germana B, Vianello F, Grassi SA, Plebani M, Di Mario F (1992) Pathophysiology of the gastric microcirculation. Ital J Gastroenterol 24:22–30PubMed
9.
go back to reference Primignani M, Carpinelli L, Preatoni P, Battaglia G, Carta A, Prada A, Cestari R, Angeli P, Gatta A, Rossi A, Spinzi G, de Franchis R (2000) Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). Gastroenterology 119:181–187PubMedCrossRef Primignani M, Carpinelli L, Preatoni P, Battaglia G, Carta A, Prada A, Cestari R, Angeli P, Gatta A, Rossi A, Spinzi G, de Franchis R (2000) Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). Gastroenterology 119:181–187PubMedCrossRef
10.
go back to reference Kitano S, Dolgor B (2000) Does portal hypertension contribute to the pathogenesis of gastric ulcer associated with liver cirrhosis? J Gastroenterol 35:79–86PubMedCrossRef Kitano S, Dolgor B (2000) Does portal hypertension contribute to the pathogenesis of gastric ulcer associated with liver cirrhosis? J Gastroenterol 35:79–86PubMedCrossRef
11.
go back to reference Tomoda J, Mizuno M, Sugihara T, Itano T, Tsuji T (1989) Gastric mucosal lesion in liver disease: Impaired gastric mucosal defence mechanism in rats with induced liver injury and in patients with liver cirrhosis. J Gastroenterol Hepatol 4(Suppl 1):136–139PubMed Tomoda J, Mizuno M, Sugihara T, Itano T, Tsuji T (1989) Gastric mucosal lesion in liver disease: Impaired gastric mucosal defence mechanism in rats with induced liver injury and in patients with liver cirrhosis. J Gastroenterol Hepatol 4(Suppl 1):136–139PubMed
12.
go back to reference Siringo S, Vaira D, Menegatti M, Piscaglia F, Sofia S, Gaetani M, Miglioli M, Corinaldesi R, Bolondi L (1997) High prevalence of Helicobacter pylori in liver cirrhosis: Relationship with clinical and endoscopic features and the risk of peptic ulcer. Dig Dis Sci 42:2024–2030PubMedCrossRef Siringo S, Vaira D, Menegatti M, Piscaglia F, Sofia S, Gaetani M, Miglioli M, Corinaldesi R, Bolondi L (1997) High prevalence of Helicobacter pylori in liver cirrhosis: Relationship with clinical and endoscopic features and the risk of peptic ulcer. Dig Dis Sci 42:2024–2030PubMedCrossRef
13.
go back to reference Lang BH, Poon RT, Fan ST, Wong J (2004) Outcomes of patients with hepatocellular carcinoma presenting with variceal bleeding. Am J Gastroenterol 99:2158–2165PubMedCrossRef Lang BH, Poon RT, Fan ST, Wong J (2004) Outcomes of patients with hepatocellular carcinoma presenting with variceal bleeding. Am J Gastroenterol 99:2158–2165PubMedCrossRef
14.
go back to reference Wu CS, Lin CY, Liaw YF (1995) Helicobacter pylori in cirrhotic patients with peptic ulcer disease:a prospective, case controlled study. Gastrointest Endosc 42:424–427PubMedCrossRef Wu CS, Lin CY, Liaw YF (1995) Helicobacter pylori in cirrhotic patients with peptic ulcer disease:a prospective, case controlled study. Gastrointest Endosc 42:424–427PubMedCrossRef
15.
go back to reference Tsai CJ (1998) Helicobacter pylori infection and peptic ulcer disease in cirrhosis. Dig Dis Sci 43:1219–1225PubMedCrossRef Tsai CJ (1998) Helicobacter pylori infection and peptic ulcer disease in cirrhosis. Dig Dis Sci 43:1219–1225PubMedCrossRef
Metadata
Title
Gastric Tissue Oxidative Changes in Portal Hypertension and Cirrhosis
Authors
Yuksel Seckin
Murat M. M. Harputluoglu
Kadir Batcioglu
Melih Karincaoglu
Bulent Yildirim
Ramazan I. Oner
Burcin Uyumlu
Nurettin Aydogdu
Fatih Hilmioglu
Publication date
01-05-2007
Published in
Digestive Diseases and Sciences / Issue 5/2007
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9139-8

Other articles of this Issue 5/2007

Digestive Diseases and Sciences 5/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.